Go to:
Logótipo
You are here: Start > Publications > View > Drug combination and repurposing for cancer therapy: the example of breast cancer
Bandeira a meia haste - A FEUP encontra-se de luto
Programa de formação da Biblioteca para o segundo semestre já está disponível
Publication

Drug combination and repurposing for cancer therapy: the example of breast cancer

Title
Drug combination and repurposing for cancer therapy: the example of breast cancer
Type
Another Publication in an International Scientific Journal
Year
2021
Authors
Correia, AS
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gartner, F
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: HeliyonImported from Authenticus Search for Journal Publications
Serial No. 6 Vol. 7
ISSN: 2405-8440
Publisher: Elsevier
Other information
Authenticus ID: P-00T-A79
Abstract (EN): Cancer is a set of extremely complex diseases, which are increasingly prominent today, as it affects and kills millions of people worldwide, being the subject of intense study both in its pathophysiology and therapy.Especially in women, breast cancer is still a cancer with a high incidence and mortality. Even though mortality rates for this type of cancer have declined in recent years, it remains challenging at the treatment level, especially the metastatic type. Due to all the impact on health, cancer therapy is the subject of costly and intense research.To enrich this therapy, as well as decrease its underlying high associated costs, drug repurposing and drug combinations are strategies that have been increasingly studied and addressed. As the name implies, drug repurposing presupposes giving new purposes to agents which, in this case, are approved for the therapy of other diseases (for example, cardiovascular or metabolic diseases), but are not approved for cancer therapy. Therefore, abetter knowledge of these therapeutic modalities for breast cancer therapy is crucial for improved therapy. In this particular review, we will discuss some relevant aspects of cancer and, particularly, breast cancer and its therapy.Also, drug combination and repurposing will be highlighted, together with relevant examples. Despite some limitations that need to be overcome, these methodologies are extremely important and advantageous incombating several current problems of cancer therapy, namely in terms of costs and resistance to current the rapeutic modalities. These approaches will be explored with a special focus on breast cancer.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 9
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

High Drug Resistance in Feline Mammary Carcinoma Cell Line (FMCm) and Comparison with Human Breast Cancer Cell Line (MCF-7) (2021)
Article in International Scientific Journal
Correia, AS; Matos, R; Gartner, F; Amorim, I; Nuno Vale

Of the same journal

Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery (2022)
Another Publication in an International Scientific Journal
Souto, EB; Fangueiro, JF; Fernandes, AR; Cano, A; Sanchez-Lopez, E; Garcia, ML; Severino, P; Paganelli, MO; Chaud, MV; Silva, AM
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in cattle production - a threat around the world (2020)
Another Publication in an International Scientific Journal
Palmeira, JD; Helena Sousa
BIM Best Practices for Construction Health and Safety: A Systematic Review (2023)
Another Publication in an International Scientific Journal
Adeeb Sidani; João Poças Martins; Alfredo Soeiro
Unsupervised and interpretable discrimination of lithium-bearing minerals with Raman spectroscopy imaging (2024)
Article in International Scientific Journal
Guimaraes, D; Monteiro, C; Teixeira, J; Lopes, T; Capela, D; Dias, F; Alexandre Lima; Jorge, PAS; Silva, NA
Towards targeted cancer therapy: Synthesis, characterization, and biological activity of a new Cu(II)-ibuprofen-2,2¿-dipyridylamine metal complex (2025)
Article in International Scientific Journal
Monteiro, PG; Gomes, A; Silva, C; Mendes, F; Almeida Paz, A; Chernyshov, D; Rocha, J; Martel, F; Santos, TM; Ferreira, BJM

See all (39)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2025-06-30 at 17:39:36 | Acceptable Use Policy | Data Protection Policy | Complaint Portal